Happy New Year from the ChEMBL Group to all our users and collaborators.
Firstly, do you want a new challenge in 2019? If so, we have a position for a bioinformatician in the ChEMBL Team to develop pipelines for identifying links between therapeutic targets, drugs and diseases. You will be based in the ChEMBL team but also work in collaboration with the exciting Open Targets initiative. More details can be found here (closing date 24thJanuary).
In case you missed it, we published a paper at the end of last on the latest developments of the ChEMBL database “ChEMBL: towards direct deposition of bioassay data”. You can read it here. Highlights include bioactivity data from patents, human pharmacokinetic data from prescribing information, deposited data from neglected disease screening and data from the IMI funded K4DD project. We have also added a lot of new annotations on the therapeutic targets and indications for clinical candidates and marketed drugs to ChEMBL. Importantly we have also enhanced the data model so that we can capture information about assays and individual bioactivities in a more structured and detailed way. The top level view of the data is essentially the same but it also enhances the options for people wanting to deposit data in ChEMBL. So if you have experimental data that you would like to make publicly available through ChEMBL please contact us at email@example.com and we would be happy to discuss with you. Incidentally this is the same email address to use if you have any questions about using ChEMBL.
Have you tried our new ChEMBL interface yet? If not please give it a go here and let us know what you think. We are still working on refining it and so it’s not too late to influence its development. If you have suggestions now is the time to let us know by emailing chembl-help.
Last but not least this year it is 10 years since the first release of ChEMBL – watch this space for more details on how we plan to celebrate this milestone …….